| 1 |
Roger Norcross |
Hoffmann-La Roche |
5 |
| 2 |
Josephine JUETTNER |
Friedrich Miescher Institute For Biomedical Research |
4 |
| 2 |
Wolfgang Richter |
Hoffmann-La Roche |
4 |
| #4 |
Glenn E. Dale |
Bioversys Ag |
3 |
| #4 |
Anna Vulpetti |
Novartis Ag |
3 |
| #4 |
Philipp Schmid |
C4 Therapeutics |
3 |
| #4 |
Simon Mariager |
Endress+Hauser Flowtec Ag |
3 |
| #4 |
Dorte Renneberg |
Actelion Pharmaceuticals |
3 |
| #9 |
Sergio Lociuro |
Bioversys Ag |
2 |
| #9 |
Ekaterina V. Breous-Nystrom |
Agenus |
2 |
| #9 |
Jacek Krol |
Friedrich Miescher Institute For Biomedical Research |
2 |
| #9 |
Rémy Kohler |
Hoffmann-La Roche |
2 |
| #9 |
Jonas Dahl |
Adobe |
2 |
| #9 |
Voichita Mihali |
Advansix Resins & Chemicals |
2 |
| #9 |
Fionn O'Hara |
Hoffmann-La Roche |
2 |
| #9 |
Laszlo Balazs Tanko |
Ferring B.V. |
2 |
| #9 |
Frank Bamberg |
Genentech |
2 |
| #9 |
Judith Flock |
Medos International Sarl |
2 |
| #9 |
Robert Müller |
Genentech |
2 |
| #9 |
Boerje HARALDSSON |
Novartis Ag |
2 |
| #9 |
Hasane Ratni |
Hoffmann-La Roche |
2 |
| #9 |
Philip Huxley |
British Biotech Pharmaceuticals |
2 |
| #9 |
Sophie Laurenson |
Abbott |
2 |
| #9 |
Christian Gossens |
Hoffmann-La Roche |
2 |
| #9 |
Carsten KROLL |
Hoffmann-La Roche |
2 |
| #9 |
Thomas Zoller |
Novartis Ag |
2 |
| #9 |
Giuseppe Cecere |
Hoffmann-La Roche |
2 |
| #9 |
Felix Aschmann |
Depuy Synthes Products |
2 |
| #9 |
Christina Hebach |
Novartis Ag |
2 |
| #9 |
Massimo Moratto |
Novartis Ag |
2 |
| #9 |
Georg Jaeschke |
Hoffmann-La Roche |
2 |
| #9 |
Grahame Woollam |
Theravance Biopharma R&D Ip |
2 |
| #9 |
Severin Kasser |
University Of Basel |
2 |
| #9 |
Alec Fettes |
Genentech |
2 |
| #9 |
Eric Andre Kusznir |
C4 Therapeutics |
2 |
| #9 |
Yuichi Nishimae |
Basf Se |
2 |
| #9 |
Dirk Schuebeler |
Friedrich Miescher Institute For Biomedical Research |
2 |
| #9 |
Timothy Kilchenmann |
F. Hoffmann-La Roche Ag |
2 |
| #9 |
Petra Schmitz |
Hoffmann-La Roche |
2 |
| #9 |
Luke Green |
Hoffmann-La Roche |
2 |
| #9 |
Stephane Courvoisier |
Straumann Holding Ag |
2 |
| #9 |
Frank Schaefer |
Robert Bosch Gmbh |
2 |
| #43 |
Christian Schutze |
Endress+Hauser Flowtec Ag |
1 |
| #43 |
Erik Jackson Bunn |
Basen |
1 |
| #43 |
Damien Maury |
Liebherr-Aerospace Toulouse Sas |
1 |
| #43 |
Florian Dalla Torre |
Straumann Holding Ag |
1 |
| #43 |
Marius Hoener |
Hoffmann-La Roche |
1 |
| #43 |
Geraint Davies |
Hoffmann-La Roche |
1 |
| #43 |
Johannes Franz Kluge |
Novartis Ag |
1 |
| #43 |
Sagar Beldar |
G1 Therapeutics |
1 |